Mexico participates in Walvax COVID-19 vaccine trials
Media
Dec 7, 2021
adn40
Trials of the Walvax vaccine against COVID-19 are being carried out in Mexico. The product is based on the mRNA, same as the moderna and pfizer vaccines. It is a biologic developed in China and 6,000 volunteers over 18 years of age are being recruited nationally.
Related Links
Nov 27, 2024
Walvax’s PCV13 Officially Exported to India
Learn More
Nov 2, 2023
Walvax presents safety and non-inferior immunogenicity results of its MPV ACYW135 compared with Menactra® at Leading Scientific Conferences
Learn More
Jul 21, 2021
CEPI partners with Shanghai Zerun Biotech to develop COVID-19 variant vaccine
Learn More